Correspondence 0001104659-24-100722 from Adagio Medical Holdings, Inc. (ADGM) (CIK 0002006986) (ADGM)
Adagio Medical Holdings, Inc. (ADGM) (CIK 0002006986)
Date: Sept. 17, 2024 · CIK: 0002006986 · Accession: 0001104659-24-100722
AI Filing Summary & Sentiment
File numbers found in text: 333-282126
Letter
VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Attn: Nicholas O’Leary Re: Adagio Medical Holdings, Inc. Registration Statement on Form S-1 File No. 333-282126
Dear Mr. O’Leary:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Adagio Medical Holdings, Inc., a Delaware corporation, hereby respectfully requests that the effective date of the above-captioned registration statement on Form S-1 (the “Registration Statement”) be accelerated so that the Registration Statement will become effective at 4:00 p.m., Eastern Time, on September 19, 2024, or as soon as practicable thereafter.
Please contact Michael S. Lee (michael.lee@reedsmith.com / telephone: (212) 549-0358) of Reed Smith LLP with any questions and please notify when this request for acceleration has been granted.
[Signature Page Follows]
Sincerely,
By:
/s/
John Dahldorf
Show Raw Text
CORRESP
1
filename1.htm
Adagio Medical Holdings, Inc.
26051
Merit Circle, Suite 102
Laguna
Hills, California 92653
September 17, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attn: Nicholas O’Leary
Re:
Adagio Medical Holdings, Inc.
Registration Statement on Form S-1
File No. 333-282126
Dear Mr. O’Leary:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Adagio Medical Holdings, Inc., a Delaware corporation, hereby respectfully requests that the effective date
of the above-captioned registration statement on Form S-1 (the “Registration Statement”) be accelerated so that
the Registration Statement will become effective at 4:00 p.m., Eastern Time, on September 19, 2024, or as soon as practicable thereafter.
Please contact Michael S. Lee (michael.lee@reedsmith.com
/ telephone: (212) 549-0358) of Reed Smith LLP with any questions and please notify when this request for acceleration has been granted.
[Signature Page Follows]
Sincerely,
By:
/s/
John Dahldorf
Name:
John Dahldorf
Title:
Chief Financial Officer
cc:
Michael S. Lee, Reed Smith LLP